宏利新推兩款儲蓄計劃 初步反應良好
宏利香港公布,推出兩款儲蓄計劃「赤霞珠終身壽險計劃2」及「世紀傳承保障計劃」,兩款儲蓄計劃均可帶來定期收入,每年派發相當於名義金額5%的保證現金儲備,其中「世紀傳承保障計劃」亦可為後代帶來長遠財務保障。
宏利香港副總裁兼首席產品總監兼康健主管紀榮道表示,相關計劃投資策略多元化及穩健,於下行周期可為客戶帶來風險管理及保障,及不錯的回報率。兩款產品上週剛進行內部發布,反應良好,但暫未有銷售數字可作公布。
另外目前宏利香港可於網上作遙距投保的產品共18款,包括3款自願醫保產品、1款延期年金產品,5款純保障產品,及9款附加保障產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.